News
Below, we highlight three promising frameworks that provide valuable guidance and resources for assessing AI chatbots in ...
The fact that lenacapavir will soon be available to patients is a testament to the strength of America's biopharmaceutical ...
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral ...
Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...
Milestone Pharmaceuticals Inc. is a strong buy under $2 with FDA approval for Cardamyst expected in 2026, offering unique ...
MONDAY, July 7, 2025 — Two babies in Oregon got sick with lead poisoning after eating baby food from Target that was ...
The FDA has approved Gamifant for the treatment of adult and pediatric patients with HLH/MAS in known or suspected Still disease.
Vita Warehouse Corp. recalled more than 40,000 bottles of Vitamin B12 supplements for possible undeclared presence of peanut.
1h
Stocktwits on MSNKalVista Stock Soars Pre-Market On FDA Approval For Drug In Treating Swelling Disorder: Retail’s ElatedKalVista Pharmaceuticals, Inc. (KALV) on Monday said that the U.S. Food and Drug Administration (FDA) has approved its drug ...
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
The steady erosion of experienced staff is slowly compromising FDA work and low morale is pushing more workers to the exit ...
ImmunityBio, Inc. (NASDAQ:IBRX) is a clinical-stage immunotherapy company that develops next-generation therapies to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results